Remus Wong
Healthcare VC
Stanford, California
Overview
Work Experience
Research Analyst
2022 - Current
• Conduct investment research, analysis, and all aspects of due diligence on life science companies. • Deal sourcing, engagement, analysis and execution to drive investment decisions. • Portfolio support, including R&D, clinical and business development.
Board Observer
2024
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
Raised $199,000,000.00 from Qatar Investment Authority, RA Capital Management, Artis Ventures (AV), Mubadala Capital, Breton Capital Management, Sahsen Ventures, Abstract, Civilization Ventures, Alexandria Venture Investments and Black Opal Ventures.
Principal Scientist
2017 - 2022
• Performed discovery to IND-enabling research on NK cell-based therapies, including experimentation, assay development, and authoring IND sections. • Managed and led collaborations with CDMOs, including technology transfer, execution of pilot/engineering/mock-GMP runs, GMP manufacturing, and release testing. • Developed cell culture process development activities, including scale-down and scale-up models, cryopreservation, media and cell culture optimization, and evaluation of bioreactor technologies.
Scientist
2016 - 2017
• First employee at the company; established at the Johnson & Johnson Innovation incubator (JLabs SSF). • Generated IP and led scientific research on early-stage projects involving synthetic biology, genome engineering using DNA recombinases and CRISPR/Cas9, and gene regulation.
Senti Biosciences is a biotechnology company that focuses on synthetic biology and gene circuit engineering for therapeutic applications.
Raised $261,500,000.00 from California Institute for Regenerative Medicine.